相关实验视频
Updated: Jul 27, 2025

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
跨研究的药理动力学分析以推动知识整合:个人患者数据元分析 (IPDMA) 的教程
Rob C van Wijk1,2, Marjorie Z Imperial1,2, Radojka M Savic1,2
1University of California San Francisco Schools of Pharmacy and Medicine, San Francisco, California, USA.
个人患者数据元分析 (IPDMA) 整合了来自多项研究的药理动力学 (PK) 数据. 这种方法通过在不同人群中进行强有力的分析并增加亚群的统计能力来增强药物开发.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物指标 (Pharmacometrics) 是一个指标.
- 药物开发 药物开发
背景情况:
- 在研究中整合药理动力学 (PK) 数据对于解决复杂的药物开发问题至关重要.
- 使用多个数据源进行知识整合,由于数据共享和先进的计算方法,正在获得引力.
- 个人患者数据元分析 (IPDMA) 为结合详细的患者级数据提供了一种强大的方法.
研究的目的:
- 提供关于在人群药动力学 (PK) 分析中进行个人患者数据元分析 (IPDMA) 的方法论的教程.
- 要突出IPDMA与标准PK建模不同的主要考虑因素.
- 引导药理学建模人员进行跨研究的综合PK数据分析.
主要方法:
- 利用数据库和文献的系统审查来获取数据.
- 使用单个患者数据对PK过程的定量建模.
- 纳入层次嵌套的变化术语以捕捉研究间的异质性.
- 在单一分析中解决测试之间的定量化极限差异.
主要成果:
- 通过IPDMA,可以在不同地区或不同人群中对PK进行表征.
- 通过IPDMA结合较小的试验可以增加亚群的统计能力.
- 该教程概述了IPDMA在人群PK分析中的具体方法调整.
结论:
- IPDMA 是一个有价值的方法来回答药物开发中的复杂问题,这些问题超出了个别研究的范围.
- 该教程提供了IPDMA实施的实用指南,重点关注研究间的变化和测试差异.
- 药理学建模人员可以使用这种方法来进行系统和彻底的整合PK数据分析.
更多相关视频
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
相关概念视频
Analysis of Population Pharmacokinetic Data
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...